Stock Trader for 18 years finding 10-100 baggers $LEU my last 100 bagger |🎖@USCG Veteran | Uranium Nuclear & Value Stock Analyst Not Financial Advice.

Joined February 2014
3,227 Photos and videos
Pinned Tweet
While I wait for Uranium to do its thing $META has caught my attention. 2015 valuation today although they are still bringing in $100 billion more dollars a year vs 2015. lowest price to discounted cash of the future ;)Long shares & Long Call Options. #uranium #stock #stockmarket
47
25
297
Uraium & the market is going parabolic Nuclear tomorrow. A visual. $UEC $LEU $SMR
14
3
62
4,054
*Uranium lol
1
3
749
Derek Quick retweeted
$NVO Novo Nordisk will likely become a trillion dollar company. I still can't believe how many key data points it ranks 1st in versus the top 10 Big Pharma companies. -Oral GLP-1's parabolic growth is going to pull a $META type move over the next 3 years. Oral GLP-1 is Meta/Instagram ad revenue. Injections are like TikTok. -Rev & adoption will show through Orals. $LLY -$NVO ranks 1st out of the top 10 Big Pharma 1st ROIC 45.29% 1st Lowest P/E 10.32 1st Pretax Margin 47.52% 1st Net Margin 37.23% 1st Highest CapEx $13.51B 1st Lowest Relative Volume 0.87 1st Global GLP-1 Market Share 1st Oral GLP-1 Launch Trajectory 1st Weekly Oral GLP-1 Prescription Growth 1st GLP-1 Prescription Scale 1st GLP-1 Brand Mindshare 1st Diabetes GLP-1 Franchise -$NVO ranks 2nd out of the top 10 Big Pharma to -$LLY -$NVO up 4% the last 5 years -$LLY up 417% 2nd Gross Margin 81.84% (LLY 82.83%) 2nd Operating Margin 45.45% (LLY 47.30%) 2nd ROE 73.79% (LLY 107.64%) 2nd Revenue Growth 16.79% (LLY 47.44%) 2nd EPS Growth 26.38% (LLY 130.14%) 2nd Highest 3 Month Performance 14.51% (LLY 18.45%) Despite ranking 1st in ROIC, Pretax Margin, Net Margin and Lowest P/E, $NVO trades at just a $193.6B market cap and 10.32x earnings. Meanwhile $LLY trades at a $1.09T market cap and 41.79x earnings. The market is pricing Novo Nordisk like the GLP-1 story is over while the fundamentals still rank among the very best in Big Pharma and leads in Oral GLP1 which is the key. Highest ROIC. Highest Pretax Margin. Highest Net Margin. Lowest P/E. Still crazy how nobody cares about my stock research posts when the stock is cheap yet after they run 400 to 1000% everyone then cares...
13
8
120
8,987
Derek Quick retweeted
$NVO Novo Nordisk's Wegovy pill was approved in the UK & available within weeks. 10,000 person waiting list. A parabolic oral GLP1 run is coming. Stock is at $43.96 $193B MC, $LLY Market cap $1.09T
2
3
57
6,274
Derek Quick retweeted
$NVO Want to buy $META at $88 again? Novo Nordisk will be the best performing stock over the next 12-36 months even in a bear market. I am sure this post will get like 10 likes,not much different when I had my Meta thesis at the lows in 2022.Oral GLP1's will change the world.
12
8
173
11,628
$NVO Want to buy $META at $88 again? Novo Nordisk will be the best performing stock over the next 12-36 months even in a bear market. I am sure this post will get like 10 likes,not much different when I had my Meta thesis at the lows in 2022.Oral GLP1's will change the world.
12
8
173
11,628
$NVO There will be signs ;) Parabolic run is coming
1
17
1,991
$NVO The market the last week -7%. This is where value will outperform. We are now number #1 on Autopilot this week. I wish I had started this fund with @joinautopilot last year, or in 2022 lol. As most of these are up 50% to 100% since my thesis last year. $OSCR $UNH $CNC
2
1
19
3,875
Derek Quick retweeted
The market. Are you buying anything? Lots of stocks down double digits. $MRVL $MU $AMD
22
1
30
8,024
Derek Quick retweeted
$UNH Since my UNH thesis post UnitedHealth Group is up around 73% & $META is down -25%. Value over everything.
$UNH I believe United Health will have a $META moment & is extremely misunderstood. This is the my basic UNH Thesis for anyone who Missed my META YOLO thesis I posted here 3 years ago, it got like 23 upvotes lol & on Twitter like a few likes. Probably will be less this time. Technicals, Double bottom forming. Not as much institutional selling as before in the April May drop. Covid lows again. 1. The Setup UNH & META are two of the most talked about stocks on WSB right now. I posted a deep value thesis on META at $88 here in 2022. Everyone laughed, Now it's pushing $800 Today, I see the same setup forming, but this time in UNH trading at Covid lows yet they make $100 billion more in REV now than in 2020 vs $22B FCF with covid Golden swan for them vs now- TTM $25B FCF. $26B with the following happening below. You find out life is just a game of inches, & the inches we need are everywhere around us ;). Every 0.5%-point drop in the medical cost ratio adds about $2 billion dollars profit,roughly 1.60 EPS. The 2026 premium reset aims for 1% to 1.5% points, worth $4 to $6 billion dollars profit around $3 to $5 EPS. A small inch in margin delivers a huge move in free cash flow for a future $500 billion revenue engine. The drop was because of the Free Cash Flow revisions that may not even happen with the above and following thesis. 2. UNH was trading at $612 just 8 months ago. Now it's in the $250s. That is a 55% draw down in a company doing $25B in free cash flow. Blue chip stock, big Institutional ownership 90% of the float paying a good DIV and doing big buybacks . It is trading like a bankrupt stock on a sandbag outlook I think will never happen. In 2028 UNH is projected to bring in over $520 billion in revenue. This will make it third in the world for revenue vs currently ranked 6th. Just a small % .5% cost cutting prints billions in free cash flow. The higher rev goes the higher the FCF will be on cost cutting. AI is going to be a MAJOR golden swan for cost cutting at UNH & nobody sees it.... Also time to cut a big % of the 440,000 workers there, just like I said in my Meta thesis, Mark needed to trim the fat & uses AI as leverage. AI - A potential Golden Swan for UNH. From UNH Annual meeting. Use of AI- We use AI to cut through complexities and empower people with a smarter, more connected experience. We are making life easier for clinicians in two ways: Reducing administrative work, freeing up clinicians to apply their expertise with greater impact, and providing powerful insights to help clinicians better, more proactively manage their patients’ health journeys. We are eliminating points of tension by delivering real-time information, closing the gap between when patients or providers need answers and when they receive them. AI is an assistant to, not a substitute for, human judgements about clinical decisions. Yeah this is fine but they need to cut like 40k or more bloat they don't need. 3. The Fails To Deliver In May, UNH had a huge FTD spike, over $150M in unsettled trades. That is rare for a mega cap & got my attention. There's likely more building now, given the new drop. Insiders continued to buy though even with the litigation that happens with most companies including META. When management is buying the most they have in years on this last pullback in May this is bullish to me. 4. Along with the AI cost cuts, Fed rate cuts & UNH Rate rise Catalysts - There's a healthcare bill S.2556 introduced in the Senate with 46 cosponsors on Day 1. It would reverse Medicaid cuts & boost UNH margins & revenue by billions. No one is pricing that in & with the OCT 1st deadline coming DEMS have leverage on this & since all of them support this day 1 its likely what they want. 5. The Play for me, I am buying cheap leap calls into 2027 building a position like I did in META. Less about the shares for me this time. Still trying to get some cheap leaps. UNH trades near $250. One options contract controls $25,000 worth of stock. Call volume has spiked. The last few days Puts spiked & market makers were selling to hedge with the EOD giving the biggest drops. Remember UNH Prints more FCF than META ever did at the bottom. Is down 60% a lot faster than METAs drop. Has policy tailwinds & management already has a plan to fix margins, basically raising the prices, The leaps here are a lot cheaper than my META leaps in 2022, I am going farther out into 2027 now too. UNH might be boring to the herd, but the setup screams to me a 2022 META play. Nobody Believes It, Same as META back then. Oversold. Hated, Ignored. But when sentiment turns this could re rate fast. TLDR: UNH is META in scrubs. They are cheaper than META was in 2022 at its lows, makes more REV & FCF than META did at the 2022 lows & has a lot of Catalysts that could re rate it overnight with a GAMMA tailwind. Lets see what happens.
2
2
36
7,802
Derek Quick retweeted
$UNH UnitedHealth Group breaking a new 52 week high. Did you buy in the $230s to $250s? You had a couple chances, might not see those ever again. $UNHG
14
2
31
5,175
Derek Quick retweeted
If you are having a bad week remember Christopher DeVocht a retail trader turned roughly $60K into over $400M, then back to nearly $0 in under 3 years trading leveraged $TSLA options. Had he simply put that $403M into the Nasdaq in 2022, it would be worth over $1B today.
4
2
69
10,317